BrUOG-E-215-neoadjuvant paclitaxel poliglumex (PPX; CT-2103), cisplatin and radiation for esophageal cancer: a phase II trial (CTIX64001)
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2013
At a glance
- Drugs Cisplatin; Paclitaxel poliglumex
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 25 Feb 2011 Results published in the American Journal of Clinical Oncology, according to a Cell Therapeutics media release.
- 26 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 24 May 2010 Results will be presented at the American Society of Clinical Oncology 2010 Annual Meeting, according to a Cell Therapeutics media release.